Showing results (121-130 of 456) with videos related to

Sort By:
Pageof 46
American Journal of Clinical Oncology|October 1, 1984
MIFA III (mitomycin-C, 5-fluorouracil, and adriamycin) chemotherapy for advanced adenocarcinoma of the pancreasC N Sternberg, G B Magill, P P Sordillo, et al.
Cancer|March 15, 1991
Prognostic factors for survival of patients with advanced urothelial tumors treated with methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapyN L Geller, C N Sternberg, D Penenberg, et al.
Urologic Oncology|December 30, 2008
Optimizing outcomes at every stage of bladder cancer: do we practice it?Harry Herr, Badrinath Konety, John Stein, et al.
Protein Expression and Purification|April 1, 1997
Rapid generation of stable cell lines expressing corticotropin-releasing hormone receptor for drug discoveryR A Horlick, K Sperle, L A Breth, et al.
American Journal of Clinical Oncology|June 1, 1987
Evaluation of new anticancer agents against human pancreatic carcinomas in nude miceC N Sternberg, P P Sordillo, E Cheng, et al.
Cancer|November 1, 1991
Transurethral resection of the prostate and metastatic prostate cancerV Pansadoro, C N Sternberg, F DePaula, et al.
BJU International|April 1, 2010
Role of targeted therapy in the treatment of advanced prostate cancerKarim Fizazi, Cora N Sternberg, John M Fitzpatrick, et al.
Hematology/Oncology Clinics of North America|April 4, 2015
Future directions and targeted therapies in bladder cancerGuru Sonpavde, Benjamin S Jones, Joaquim Bellmunt, et al.
Cancer|December 26, 2001
Chemotherapy with an every-2-week regimen of gemcitabine and paclitaxel in patients with transitional cell carcinoma who have received prior cisplatin-based therapyC N Sternberg, F Calabrò, G Pizzocaro, et al.
Drugs|May 21, 2010
Castration-resistant prostate cancer: current and emerging treatment strategiesGiuseppe Di Lorenzo, Carlo Buonerba, Riccardo Autorino, et al.
Pageof 46